Fulgent Genetics' 15min chart shows KDJ Death Cross, Bearish Marubozu.

Fulgent Genetics's 15-minute chart has triggered a KDJ Death Cross and a Bearish Marubozu at 08/19/2025 13:45, indicating a shift in momentum towards the downside and a potential for further decreases in stock price. Sellers are currently in control of the market, and the bearish momentum is likely to persist.

Fulgent Genetics' (NASDAQ: FLGT) 15-minute chart has triggered a significant technical signal, indicating a potential shift in the stock's momentum towards the downside. At 08/19/2025 13:45, the chart displayed a KDJ Death Cross and a Bearish Marubozu pattern, suggesting a bearish trend and further potential decreases in stock price.

The KDJ Death Cross is a bearish technical indicator that signals a shift in the momentum of the stock price towards the downside. This pattern occurs when the K line crosses below the D line on the KDJ indicator, indicating a potential reversal in the stock's trend [1]. The Bearish Marubozu pattern, which appeared on August 19, 2025, at 13:45, further supports this bearish sentiment. This pattern is characterized by a single candle with no upper wick, indicating strong selling pressure and a potential downward trend [2].

Despite mixed financial performance reported in the second quarter of 2025, Fulgent Genetics raised its full-year core revenue guidance to $320 million, reflecting strong momentum in its laboratory services and therapeutic development businesses [3]. However, the technical analysis indicates a bearish trend, with the KDJ Death Cross and Bearish Marubozu signaling a downward momentum in the stock price [4].

Looking ahead, Fulgent Genetics has forecasted average revenue growth of 9.0% per annum over the next three years, compared to a 6.0% industry growth forecast for the U.S. healthcare sector [1]. However, the technical analysis suggests a bearish trend, with a KDJ Death Cross and a Bearish Marubozu signaling a downward momentum in the stock price [4].

References:
[1] https://finance.yahoo.com/news/fulgent-genetics-second-quarter-2025-131814335.html
[2] https://www.tipranks.com/news/company-announcements/fulgent-genetics-reports-q2-2025-financial-results
[3] https://www.marketbeat.com/instant-alerts/fulgent-genetics-nasdaqflgt-shares-gap-up-after-earnings-beat-2025-08-01/
[4] https://www.investing.com/news/transcripts/earnings-call-transcript-fulgent-genetics-q2-2025-exceeds-revenue-forecast-stock-surges-93CH-4166152